Dana-Farber Cancer Institute
3 stories
-
healthNew Pancreatic Cancer Pill Shows Promise, 90% of Patients Respond in Early Trial
An experimental daily pill, daraxonrasib, shows a 90% disease control rate in advanced pancreatic cancer patients during early-stage clinical trials.
-
healthEarly Onset Colorectal Cancer: A Growing Concern for Younger Adults
Colorectal cancer diagnoses are rising in individuals under 50. Experts discuss causes, symptoms, and treatment for this concerning trend.
-
healthAlarming Rise in Early-Onset Colorectal Cancer: Experts Weigh In
Colorectal cancer rates are surging in individuals under 50. Leading oncologist Dr. Laura Van Metre Baum discusses causes, symptoms, and the critical need for awareness.